John M. McAdam
2010
In 2010, John M. McAdam earned a total compensation of $217.5K as Former Vice President, Finance and Accounting at Amicus Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Option Awards | $29,756 |
|---|---|
| Salary | $159,231 |
| Other | $28,501 |
| Total | $217,488 |
McAdam received $159.2K in salary, accounting for 73% of the total pay in 2010.
McAdam also received $29.8K in option awards and $28.5K in other compensation.
Rankings
In 2010, John M. McAdam's compensation ranked 9,681st out of 10,439 executives tracked by ExecPay. In other words, McAdam earned more than 7.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,681 out of 10,439 | 7th |
Division Manufacturing | 3,593 out of 3,838 | 6th |
Major group Chemicals And Allied Products | 862 out of 921 | 6th |
Industry group Drugs | 635 out of 680 | 7th |
Industry Pharmaceutical Preparations | 455 out of 481 | 5th |
Source: SEC filing on April 25, 2011.
McAdam's colleagues
We found five more compensation records of executives who worked with John M. McAdam at Amicus Therapeutics in 2010.
2010
John Crowley
Amicus Therapeutics
Chief Executive Officer
2010
David Lockhart
Amicus Therapeutics
Chief Scientific Officer
2010
Matthew Patterson
Amicus Therapeutics
Former President
2010
Pol Boudes
Amicus Therapeutics
Chief Medical Officer
2010
Mohan Ganesan
Amicus Therapeutics